Clare Y Slaney (Clare Slaney)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

Cancers

Nature communications

Clinical & translational immunology

Clinical cancer research : an official journal of the American Association for Cancer Research

Peter MacCallum Cancer Centre

University of Auckland (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peter MacCallum Cancer Centre

Australia

Research Fellow :: Research

Education History

University of Auckland

New Zealand

MSC :: School of Biological Sciences

Victoria University of Wellington

New Zealand

PHD :: Malaghan Institute of Medical Research

Publications

Evan G Pappas, Michael H Kershaw, Clare Y Slaney
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges. Cancers 15 (4) (2023)
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, Zixuan Zhao, Clare Y Slaney, Jarryd Boath, Luc Furic, Christopher Angel, Stephen M Jane, Wayne A Phillips, Steven A Stacker, Camile S Farah, Charbel Darido
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Nature communications 14 (1) (2023)
Deborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean MacDonald, Thu Ngoc Nguyen, Minyu Wang, Niko Thio, Criselle D'Souza, Vicky Mengfei Qin, Clare Y Slaney, Aaron Harrison, Kevin Sek, Pasquale Petrone, Kevin Thia, Lauren Giuffrida, Andrew Mark Scott, Rachael L Terry, Ben Tran, Jayesh Desai, Henry Miles Prince, Simon James Harrison, Paul A Beavis, Michael H Kershaw, Benjamin J Solomon, Paul G Ekert, Joseph A Trapani, Phillip K Darcy, Paul Joseph Neeson
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models. Science translational medicine 15 (690) (2023)
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, Zixuan Zhao, Clare Y Slaney, Jarryd Boath, Luc Furic, Christopher Angel, Stephen M Jane, Wayne A Phillips, Steven A Stacker, Camile S Farah, Charbel Darido
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Nature communications 14 (1) (2023)
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, Zixuan Zhao, Clare Y Slaney, Jarryd Boath, Luc Furic, Christopher Angel, Stephen M Jane, Wayne A Phillips, Steven A Stacker, Camile S Farah, Charbel Darido
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. Nature communications 14 (1) (2023)
Evan G Pappas, Michael H Kershaw, Clare Y Slaney
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges. Cancers 15 (4) (2023)
Daniela Gm Tantalo, Amanda J Oliver, Bianca von Scheidt, Aaron J Harrison, Scott N Mueller, Michael H Kershaw, Clare Y Slaney
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies. Journal for immunotherapy of cancer 9 (5) (2022)
Aesha I Ali, Minyu Wang, Bianca von Scheidt, Pilar M Dominguez, Aaron J Harrison, Daniela G M Tantalo, Jian Kang, Amanda J Oliver, Jack D Chan, Xin Du, Yuchen Bai, Belinda Lee, Ricky W Johnstone, Phillip K Darcy, Michael H Kershaw, Clare Y Slaney
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Peter Kar Han Lau, Carleen Cullinane, Susan Jackson, Rachael Walker, Lorey K Smith, Alison Slater, Laura Kirby, Riyaben P Patel, Bianca von Scheidt, Clare Y Slaney, Grant A McArthur, Karen E Sheppard
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma. Cancers 13 (24) (2021)
Jack D Chan, Bianca von Scheidt, Bijun Zeng, Amanda J Oliver, Ashleigh S Davey, Aesha I Ali, Ranjeny Thomas, Joseph A Trapani, Phillip K Darcy, Michael H Kershaw, Riccardo Dolcetti, Clare Y Slaney
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells. Clinical & translational immunology 9 (7) (2020)
Amanda J Oliver, Phillip K Darcy, Joseph A Trapani, Michael H Kershaw, Clare Y Slaney
Cross-talk between tumors at anatomically distinct sites. The FEBS journal 288 (1) (2020)
Clare Y Slaney, Michael H Kershaw
Challenges and Opportunities for Effective Cancer Immunotherapies. Cancers 12 (11) (2020)
Jonas R M Van Audenaerde, Elly Marcq, Bianca von Scheidt, Ashleigh S Davey, Amanda J Oliver, Jorrit De Waele, Delphine Quatannens, Jinthe Van Loenhout, Patrick Pauwels, Geert Roeyen, Filip Lardon, Clare Y Slaney, Marc Peeters, Michael H Kershaw, Phillip K Darcy, Evelien Ljm Smits
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment. Clinical & translational immunology 9 (8) (2020)

Clare Y Slaney.css-eqlu8i{font-size:small;padding-left:4px;} (Clare Slaney)

Publication Activity (10 Years)

Top Topics

Top Venues

Clare Y Slaney (Clare Slaney)